Koshinski Asset Management, Inc. Gamida Cell Ltd. Transaction History

Koshinski Asset Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$1.73 - $4.29 $865 - $2,145	-500 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$2.22 - $4.47 $666 - $1,341	-300 Reduced 37.5%	500 $2.08 Million
Q3 2021 Oct 12, 2021	BUY	$3.85 - $6.44 $3,080 - $5,152	800 New	800 $3,000

11.4M

235K

70.5K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Koshinski Asset Management, Inc. with notifications on news.